anhydroecgonine methyl ester has been researched along with ritanserin in 1 studies
Studies (anhydroecgonine methyl ester) | Trials (anhydroecgonine methyl ester) | Recent Studies (post-2010) (anhydroecgonine methyl ester) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
---|---|---|---|---|---|
52 | 0 | 13 | 735 | 75 | 71 |
Protein | Taxonomy | anhydroecgonine methyl ester (IC50) | ritanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
1 other study(ies) available for anhydroecgonine methyl ester and ritanserin
Article | Year |
---|---|
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |